Analystreport

Stoke Therapeutics, Inc. (NASDAQ: STOK) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating.

Stoke Therapeutics, Inc.  (STOK) 
Last stoke therapeutics, inc. earnings: 11/12 08:00 am Check Earnings Report